Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca M. Marin, Jann N. Sarkaria, Jason E. Conage‐Pough et al.|Neuro-Oncology|2021Cited by 81
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse modelsJason E. Conage‐Pough, Forest M. White, Sylwia A. Stopka et al.|Neuro-Oncology Advances|2023Cited by 5